Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Type of study
Language
Document Type
Year range
1.
7th International Congress on Information and Communication Technology, ICICT 2022 ; 464:353-363, 2023.
Article in English | Scopus | ID: covidwho-1971622

ABSTRACT

This study aims to determine the success of using the PeduliLindungi application in Indonesia. The government created the PeduliLindungi application in dealing with COVID-19 in Indonesia, integrated nationally. The PeduliLindungi application is one of the government’s breakthroughs in handling the COVID-19 pandemic. The PeduliLindungi application has several challenges: how people trust the application, the role of the application in daily life, and how the government can make a strategy so that people are sure of using the PeduliLindungi application. The data used in this study is a qualitative descriptive data and Twitter data related to public responses. This study used a QDAS approach to analyze the NVIVO Plus 12 software. The results showed that the PeduliLindungi application provided convenience to users through the features on the application offered. The PeduliLindungi application components include COVID-19 test results, Ehac, teledokter, COVID-19 statistical information, and vaccination registration. The government also has a good strategy in convincing the public to use the PeduliLindungi application by making rules that explain the obligation to use the PeduliLindungi application in daily life during the COVID-19 pandemic. This rule makes the number of PeduliLindungi application users increase each month. However, the PeduliLindungi application also received criticism from application users regarding complaints in using the PeduliLindungi application, such as application errors, data leaks, and user data errors. This criticism can be used as an evaluation material for the government to improve the quality of the PeduliLindungi application. © 2023, The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

SELECTION OF CITATIONS
SEARCH DETAIL